Can a mobile BiPAP device reduce dyspnea when climbing stairs in patients with moderate to severe COPD? - A randomized crossover study

Not Applicable

• Conditions: J44.8; Other specified chronic obstructive pulmonary disease

• Registration Number: DRKS00017613
• Lead Sponsor: ungenklinik Köln Merheim

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting stopped after recruiting started
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

COPD stages III and IV
- Definition on the basis of the GOLD Guideline
- Exclusion of acute exacerbation
- Signed consent form
- Patient age = 18 years

Exclusion Criteria

- Patient age < 18 years
- Mental retardation
- Missing declaration of consent
- Acute exacerbation of the disease
- gait uncertainty

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean difference of the Borg dyspnoea scale before and after completion of the stair climbing test with and without use of the mobile BiPAP device VitaBreath.

Secondary Outcome Measures

Name	Time	Method
- Results of blood gas analysis after climbing stairs<br>- Time until the specified number of stairs is reached<br>- Results of the SPO2 measurement before and after exercise